Kalaris Therapeutics, Inc.
For the period ended Jun 6, 2024. Filed Apr 23, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 6, 2024 · Filed Apr 23, 2024
KLRS$2.42+2.5%Stored close · as of Nov 6, 2026
Contents
FOR
THE RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.